1-9 of 9
Christoph Q. Schmidt
Close
Sort by
Journal Articles

It’s all about complement balance, again

Christoph Q. Schmidt
Journal: Blood
Blood (2024) 143 (11): 949–951.
https://doi.org/10.1182/blood.2023023334
Published: 2024
Journal Articles

Complement and the prothrombotic state

Christoph Q. Schmidt, Hubert Schrezenmeier, David Kavanagh
Journal: Blood
Blood (2022) 139 (13): 1954–1972.
https://doi.org/10.1182/blood.2020007206
Published: 2022
Journal Articles

Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity

Marco Mannes, Arthur Dopler, Oliver Zolk, Sophia J. Lang, Rebecca Halbgebauer, Britta Höchsmann, Arne Skerra, Christian K. Braun, Markus Huber-Lang, Hubert Schrezenmeier, Christoph Q. Schmidt
Journal: Blood
Blood (2021) 137 (4): 443–455.
https://doi.org/10.1182/blood.2020005959
Published: 2021
Includes: Supplemental data
Journal Articles

Complement and coagulation: so close, yet so far

Christoph Q. Schmidt, Admar Verschoor
Journal: Blood
Blood (2017) 130 (24): 2581–2582.
https://doi.org/10.1182/blood-2017-10-811943
Published: 2017
Journal Articles

Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation

Markus J. Harder, Nadine Kuhn, Hubert Schrezenmeier, Britta Höchsmann, Inge von Zabern, Christof Weinstock, Thomas Simmet, Daniel Ricklin, John D. Lambris, Arne Skerra, Markus Anliker, Christoph Q. Schmidt
Journal: Blood
Blood (2017) 129 (8): 970–980.
https://doi.org/10.1182/blood-2016-08-732800
Published: 2017
Includes: Supplemental data
Journal Articles

Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria

Brief Report
Zhuoer Lin, Christoph Q. Schmidt, Sophia Koutsogiannaki, Patrizia Ricci, Antonio M. Risitano, John D. Lambris, Daniel Ricklin
Journal: Blood
Blood (2015) 126 (7): 891–894.
https://doi.org/10.1182/blood-2015-02-625871
Published: 2015
Includes: Supplemental data
Journal Articles

Novel Complement Modulators for Paroxysmal Nocturnal Hemoglobinuria: Peptide and Protein Inhibitors of C3 Convertase Prevent Both Surface C3 Deposition and Subsequent Hemolysis of Affected Erythrocytes in Vitro

Antonio M. Risitano, MD, PhD, Patrizia Ricci, Caterina Pascariello, Maddalena Raia, Christoph Q Schmidt, Yingxue Li, Edimara S Reis, Michela Sica, PhD, Rosario Notaro, MD, Luigi Del Vecchio, MD, Fabrizio Pane, Daniel Ricklin, John D Lambris
Journal: Blood
Blood (2012) 120 (21): 370.
https://doi.org/10.1182/blood.V120.21.370.370
Published: 2012
Journal Articles

Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes

Wai-Hong Tham, Christoph Q. Schmidt, Richard E. Hauhart, Mara Guariento, Patience B. Tetteh-Quarcoo, Sash Lopaticki, John P. Atkinson, Paul N. Barlow, Alan F. Cowman
Journal: Blood
Blood (2011) 118 (7): 1923–1933.
https://doi.org/10.1182/blood-2011-03-341305
Published: 2011
Includes: Supplemental data
Journal Articles

Association of factor H autoantibodies with deletions of CFHR1 , CFHR3 , CFHR4 , and with mutations in CFH , CFI , CD46 , and C3 in patients with atypical hemolytic uremic syndrome

Iain Moore, Lisa Strain, Isabel Pappworth, David Kavanagh, Paul N. Barlow, Andrew P. Herbert, Christoph Q. Schmidt, Scott J. Staniforth, Lucy V. Holmes, Roy Ward, Lynn Morgan, Timothy H. J. Goodship, Kevin J. Marchbank
Journal: Blood
Blood (2010) 115 (2): 379–387.
https://doi.org/10.1182/blood-2009-05-221549
Published: 2010